who/hiv/2017.59 chad · recommending treat all later in 2017 tdf/3tc(ftc)/efv first line arvs only...

2
M Estimated % of pregnant women living with HIV who received ARVs for PMTCT $ $ $ HIV Country Profile: 2016 Total population (2016) Life expectancy at birth (2015-2020) GNI per capita, PPP (2015) Estimated ART coverage children and adults Health expenditure per capita (2014) Health expenditure, total (% of GDP) (2014) Maternal mortality per 100 000 live births (2015) Trend since 2010 Human Development Index Value (2015) Total fertility rate (births per woman) (2015-2020) Number of births (thou- sands) (2015-2020) Trend since 2010 Epidemiological HIV data Value [range] Estimated number of people living with HIV Estimated number of children aged 0 to 14 living with HIV Estimated number of women (15+) living with HIV Estimated adult (15-49) prevalence Estimated number of deaths due to HIV Estimated number of children dying due to HIV Estimated number of people newly infect- ed with HIV Estimated number of children newly infect- ed with HIV Estimated incidence rate per 1 000 unin- fected population Antiretroviral therapy (ART) Reported number of people receiving ART Estimated ART coverage Reported number of children receiving ART Estimated ART coverage (children, 0-14)* 1 Value [range] Year Antenatal care coverage - at least one visit (%) Antenatal care coverage - at least four visits (%) % of pregnant women with known HIV status Antenatal care attendees who were tested for syphilis (%) Antenatal care attendees who tested posi- tive for syphilis (%) Antenatal care attendees who tested posi- tive for syphilis and who received benzathi- ne penicillin IM (%) Reported number of pregnant women living with HIV who received antiretrovirals for PMTCT Estimated % of pregnant women living with HIV who received antiretrovirals for PMTCT* 2 % of infants born to women living with HIV receiving a virological test within two months of birth (EID)* 1 Final mother-to-child transmission rate including breastfeeding period* 3 Elimination of mother-to-child transmission (EMTCT) of HIV and syphilis World Bank UNPOP UNPOP UNPOP World Health Stat., WHO World Bank UNPOP World Bank 90-90-90 progress towards 2020 targets Demographic and socioeconomic data Estimated number of people newly infected with HIV Estimated number of deaths due to AIDS UNPOP * Tracing indicators for elimination of mother-to-child transmission. A colour scheme (green, orange, red) is used to indicate if the country is on target to meet 2020 targets: ¹90% ²95% ³Less than 5 WHO/HIV/2017.59 million US$ % years US$ 110 000 [94 000 - 130 000] 11 000 [7 600 - 14 000] 59 000 [50 000 - 69 000] 1.3% [1.0% - 1.5%] 2 800 [1 900 - 4 000] <1000 [<500 - <1000] 4 800 [ 3 400 - 6 400] <1000 [<500 - 1 500] 0.34 [0.24 - 0.46] 44 200 39% [33% - 46%] 1 500 14% [9% - 18%] 14.5 2 110 856 3.6 53 37 5.8 0.40 3 223 Chad 22% 42% 14% 0 2 000 4 000 6 000 8 000 10 000 12 000 14 000 16 000 2016 2010 2005 2000 0 2 000 4 000 6 000 8 000 10 000 2016 2010 2005 2000 63% 0% 20% 40% 60% 80% 100% N/A 39% 32% PLHIV diagnosed PLHIV receiving ART PLHIV virally suppressed 55% 31% 32% 100% 4 400 63% [44% - 79%] 5% [4% - 7%] 14.2 2014-2015 2006 2015 2014 2016 2016 2016 2016

Upload: others

Post on 08-Nov-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: WHO/HIV/2017.59 Chad · Recommending Treat All later in 2017 TDF/3TC(FTC)/EFV first line ARVs only Implemented countrywide Fully implemented Unknown Partially Data not reported Data

0

100

200

300

400

500

600

700

800

900

2010 2011 2012 2013 2014 2015 2016Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[TDF+FTC]+[LPV/r] [TDF+3TC]+[LPV/r] [ZDV+3TC]+[LPV/r]

[TDF+3TC]+[ATV/r]

0

50

100

150

200

250

300

350

400

2010 2011 2012 2013 2014 2015 2016

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC+NVP] [150+200+300] [TDF+FTC+EFV] [600+200+300] [TDF+3TC+EFV] [600+300+300]

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC]+[ATV/r]

Estimated % of pregnant women living with HIV who received ARVs

for PMTCT

$

$

$

HIV Country Profile: 2016

Total population (2016)

Life expectancy at birth (2015-2020)

GNI per capita, PPP (2015)

Estimated ART coveragechildren and adults

Health expenditure per capita (2014)

Health expenditure, total (% of GDP) (2014)

Maternal mortality per 100 000 live births (2015)

Trend since 2010

Human Development Index Value (2015)

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

Total fertility rate (births per woman) (2015-2020)

Number of births (thou-sands) (2015-2020)

Trend since 2010

Epidemiological HIV data Value [range]

Estimated number of people living with HIV

Estimated number of children aged 0 to 14 living with HIV

Estimated number of women (15+) living with HIV

Estimated adult (15-49) prevalence

Estimated number of deaths due to HIV

Estimated number of children dying due to HIV

Estimated number of people newly infect-ed with HIV

Estimated number of children newly infect- ed with HIV

Estimated incidence rate per 1 000 unin-fected population

Antiretroviral therapy (ART)

Reported number of people receiving ART

Estimated ART coverage

Reported number of children receiving ART

Estimated ART coverage (children, 0-14)*1

Value [range] Year

Antenatal care coverage - at least one visit (%)

Antenatal care coverage - at least four visits (%)

% of pregnant women with known HIV status

Antenatal care attendees who were tested for syphilis (%)

Antenatal care attendees who tested posi- tive for syphilis (%)

Antenatal care attendees who tested posi- tive for syphilis and who received benzathi-ne penicillin IM (%)

Reported number of pregnant women living with HIV who received antiretrovirals for PMTCT

Estimated % of pregnant women living with HIV who received antiretrovirals for PMTCT*2

% of infants born to women living with HIV receiving a virological test within two months of birth (EID)*1

Final mother-to-child transmission rate including breastfeeding period*3

Elimination of mother-to-child transmission (EMTCT) of HIV

and syphilis

World Bank UNPOP

UNPOP UNPOP

World Health Stat., WHO World Bank

UNPOP World Bank

90-90-90 progress towards 2020 targetsDemographic and socioeconomic data

Estimated number of people newly infected with HIV

Estimated number of deaths due to AIDS

UNPOP

* Tracing indicators for elimination of mother-to-child transmission. A colour scheme (green, orange, red) is used to indicate if the country is on target to meet 2020 targets: ¹90% ²95% ³Less than 5

WHO/HIV/2017.59

million US$

%

years US$

110 000 [94 000 - 130 000]

11 000 [7 600 - 14 000]

59 000 [50 000 - 69 000]

1.3% [1.0% - 1.5%]

2 800 [1 900 - 4 000]

<1000 [<500 - <1000]

4 800 [ 3 400 - 6 400]

<1000 [<500 - 1 500]

0.34 [0.24 - 0.46]

44 200

39% [33% - 46%]

1 500

14% [9% - 18%]

14.5 2 110

856 3.6

53 37

5.8 0.40

3 223

Chad

22%

42%

14%

0

2 000

4 000

6 000

8 000

10 000

12 000

14 000

16 000

20162010200520000

2 000

4 000

6 000

8 000

10 000

2016201020052000

63%

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

N/A

39%32%

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

55%

31%

32%

100%

4 400

63% [44% - 79%]

5% [4% - 7%]

14.2

2014-2015

2006

2015

2014

2016

2016

2016

2016

Page 2: WHO/HIV/2017.59 Chad · Recommending Treat All later in 2017 TDF/3TC(FTC)/EFV first line ARVs only Implemented countrywide Fully implemented Unknown Partially Data not reported Data

HIV Country Profile: 2016

Median annual price of ARV drug regimens for adults

Implementation of national policy on HIV self-testing (HIVST)

Treatment initiation threshold children

Treatment initiation threshold adults and adolescents

Implementation of Treat All adults and adolescents

Dolutegravir (DTG) as part of 1st line ARVs for adults and adolescents

Implementation of lifelong ART to pregnant & breastfeeding women

Implementation of national policy on viral load monitoring

Completion of HIV services cascades

Adaptation of WHO Key Population guidelines in national plans

National M&E plan or strategy for HIV

Method to de-duplicate key data (i.e. unique identifiers)

Nationally-representative quality assessment of facility-level ART data

National HIV policies and plans

0

100

200

300

400

500

600

700

800

900

2010 2011 2012 2013 2014 2015 2016Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[TDF+FTC]+[LPV/r] [TDF+3TC]+[LPV/r] [ZDV+3TC]+[LPV/r]

[TDF+3TC]+[ATV/r]

0

50

100

150

200

250

300

350

400

2010 2011 2012 2013 2014 2015 2016

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC+NVP] [150+200+300] [TDF+FTC+EFV] [600+200+300] [TDF+3TC+EFV] [600+300+300]

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC]+[ATV/r]

First line Second line

Sources: Global AIDS Monitoring (UNAIDS/WHO/UNICEF), Spectrum estimates (UNAIDS/WHO) and WHO HIV Country Intelligence Tool, 2017

WHO/HIV/2017.59

* Tracing indicators for elimination of mother-to-child transmission. A colour scheme (green, orange, red) is used to indicate if the country is on target to meet 2020 targets: ¹90% ²95% ³Less than 5

WHO/HIV/2017.59

0

50

100

150

200

250

2010 2011 2012 2013 2014 2015 2016

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC+NVP] [150+200+300]mg [TDF+FTC+EFV] [600+200+300]mg [TDF+3TC+EFV] [600+300+300]mg

0

100

200

300

400

500

600

2010 2011 2012 2013 2014 2015 2016

Me

dia

n p

rice

in

US

do

lla

rs p

er

pe

rso

n p

er

ye

ar

[TDF+FTC]+[LPV/r] [TDF+3TC]+[LPV/r] [ZDV+3TC]+[LPV/r] [TDF+3TC]+[ATV/r] [ZDV+3TC]+[ATV/r]

No policy

Treat All, with an age cut-off <1 year

Treat All regardless of CD4 count

Recommending Treat All later in 2017

TDF/3TC(FTC)/EFV first line ARVs only

Implemented countrywide

Fully implemented

Unknown

Partially

Data not reported

Data not reported

Data not reported

ChadKey populations

Needles distributed per person who inject drugs per year …

Percentage of men reporting using a condom the last time they had anal sex with a male partner …

HIV prevalence among sex workers (%) …

Percentage condom use among sex workers with most recent client …

2014-2015

2006

2015

2014

2016

2016

2016

2016